Flumazenil (0.5mg)

Clinical Pharmacologist's Monograph

⚠️ Prescription Only: This medicine is Schedule H/H1. Do not self-medicate.

1. Clinical Overview

Flumazenil is a competitive benzodiazepine receptor antagonist. It is a specific, potent, and rapidly acting antidote used to reverse the sedative effects of benzodiazepines. It is a white to off-white crystalline powder, poorly soluble in water, and is administered intravenously. In the Indian context, it is a critical drug in emergency and ICU settings for managing benzodiazepine overdose and reversal of procedural sedation.

OnsetDurationBioavailability
1-2 minutes after intravenous administration.The duration is dose-dependent and typically 30-60 minutes, but may be shorter than the duration of action of the benzodiazepine being reversed, necessitating careful monitoring for resedation.Approximately 100% following intravenous administration (the only approved route). Oral bioavailability is low (<15%) due to extensive first-pass metabolism.

2. Mechanism of Action

Flumazenil competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex (GABA-A receptor). It does not antagonize the CNS effects of other GABA-ergic agents, opioids, barbiturates, or ethanol.

3. Indications & Uses

  • Complete or partial reversal of the sedative effects of benzodiazepines in general anesthesia.
  • Management of benzodiazepine overdose (as an adjunct to supportive care).

4. Dosage & Administration

Adult Dosage: Initial: 0.2 mg IV over 15 seconds. If desired level of consciousness is not achieved after 60 seconds, a further dose of 0.1 mg can be given every 60 seconds. Maximum total dose: 1 mg (2 vials of 0.5 mg). For suspected resedation: Repeat regimen at 20-minute intervals, not exceeding 1 mg per episode and 3 mg per hour.

Administration: For IV use only. Administer into a large vein to minimize pain at injection site. Can be given as a bolus or by continuous infusion (0.1-0.5 mg/hr) for resedation prophylaxis. Must be administered in a setting where full resuscitation equipment and personnel are available. Compatible with 5% Dextrose, Ringer's Lactate, and Normal Saline.

5. Side Effects

Common side effects may include:

  • Nausea
  • Vomiting
  • Agitation
  • Anxiety
  • Pain at injection site
  • Dizziness

6. Drug Interactions

DrugEffectSeverity
Benzodiazepines (e.g., Midazolam, Diazepam)Flumazenil reverses their sedative, anxiolytic, and anticonvulsant effects.Major
Tricyclic Antidepressants (e.g., Amitriptyline)Increased risk of seizures and arrhythmias when flumazenil is used in mixed overdose.Contraindicated
TheophyllineMay lower seizure threshold; use with extreme caution.Major
Non-Benzodiazepine Hypnotics (Z-drugs like Zolpidem)Partial reversal may occur as they act on a subset of GABA-A receptors.Moderate
CYP3A4 Inhibitors (e.g., Ketoconazole, Erythromycin)May increase flumazenil plasma levels, prolonging its effect.Moderate
CYP3A4 Inducers (e.g., Rifampicin, Carbamazepine)May decrease flumazenil plasma levels, shortening its effect.Moderate

7. Patient Counselling

  • DO inform the doctor of all medications, especially antidepressants and epilepsy drugs.
  • DO expect to be monitored closely in a hospital for at least 1-2 hours after administration.
  • DONT attempt to drive or operate heavy machinery for at least 24 hours.
  • DONT consume alcohol or any other sedative medications for 24 hours.

8. Toxicology & Storage

Overdose: Isolated flumazenil overdose is unlikely to cause significant toxicity in a healthy individual, as it has minimal intrinsic activity. Symptoms may include anxiety, agitation, increased muscle tone, and possibly seizures if there is an underlying propensity. The primary risk is from unmasking the effects of other co-ingested drugs or precipitating benzodiazepine withdrawal.

Storage: Store below 25°C. Protect from light and freezing. The prepared solution for infusion (in compatible IV fluids) is chemically and physically stable for up to 24 hours at room temperature. Do not mix with other drugs in the same syringe or infusion bag. For single use only. Discard any unused portion.